$KEYS

Dhanasekaran Satish sold $183K of KEYS

Dhanasekaran Satish (President and CEO) sold 507 shares of Keysight Technologies, Inc. (KEYS) at $361.32 ($0.18M total) on 2026-06-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dhanasekaran Satish
Published Jun 29, 2026, 11:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 12:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEYS
Neutral
high confidence
Mentioned
$KEYS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEYSNeutralLow
01

Why it matters

The CEO’s open-market sale is disclosed with a 10b5-1 plan, which generally lowers the informational content versus non-10b5-1 discretionary sales.

02

Market read

Traders may note the CEO’s scheduled selling, but the 10b5-1 structure suggests limited incremental fundamental impact.

03

What to watch

The article provides only the sale size and post-transaction holdings; it does not include any offsetting buys or broader context on compensation/vesting that could explain the transaction.

Relevance 3/10Novelty 5/10Timing: SEC Form 4 filed 2026-06-29 (sale dated 2026-06-25)

Background

This is an SEC Form 4 insider transaction disclosure for Keysight Technologies, Inc. (KEYS).

Company-level read

Ticker impact

$KEYSNeutralHigh confidence
Context

Keysight CEO sold 507 shares in an open-market transaction ($183,189) under a pre-arranged 10b5-1 plan filed on SEC EDGAR.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely muted.

Evidence & confidence

The filing is a disclosed open-market sale with 10b5-1 pre-arrangement, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; insider sale does not change sector fundamentals for test-and-measurement equipment.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Keysight Technologies, Inc.

    Issuer of the Form 4 insider transaction; CEO sold shares under a pre-arranged 10b5-1 plan.

  • Dhanasekaran Satish

    President and CEO; reported open-market sale of 507 shares at $361.32 on 2026-06-25.

Related articles

$KEYSMed

Keysight's RFPro Software Certified for Intel's 14A and 18A-P Process Technologies

Keysight Technologies said its RFPro electromagnetic design software has been certified for Intel Foundry’s 14A and 18A-P process technologies, allowing chip designers to simulate performance before manufacturing. The company said this builds on existing support for Intel’s 18A and EMIB-T packaging. The article notes KEYS shares fell about 3.6% to $307.25 and Intel about 3.1% to $89.47.

$KEYSMed

Keysight Technologies, Inc.: Keysight and Sateliot Selected by European Space Agency to Develop Blockchain-Enabled Framework for 5G Non-Terrestrial Networks

Keysight Technologies (NYSE: KEYS) was selected by the European Space Agency to lead a three-year ESA ARTES program developing a blockchain-enabled, secure anomaly detection framework for 5G non-terrestrial networks. Keysight will work with Sateliot on technical development and satellite mission integration, aiming to support trusted NTN operations and future 6G/AI network assurance.

$KEYSMed

Morgan Stanley Says This AI Pick and Shovel Stock Has 25% Upside

Morgan Stanley upgraded Keysight Technologies (NYSE: KEYS) to Overweight from Equal Weight and raised its price target to $400 from $350. The target implies about 25% upside versus a $319 share price. The firm cites Keysight as an AI “pick-and-shovel” for testing at higher networking speeds and notes strong AI-related revenue growth.

$AXPMed

American Express, Biogen upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. JPMorgan raised American Express (AXP) to Overweight, PT $400. Truist upgraded Biogen (BIIB) to Buy, PT $235, citing upcoming Phase 2 and Phase 3 readouts. JPMorgan also raised Keysight (KEYS) to Overweight, PT $400. Other actions included upgrades for Humana (HUM) and downgrades for Papa John’s (PZZA) and Best Buy (BBY).

$KEYSMedAI 8/10

Cybeats Technologies Corp.: Cybeats Technologies Corp. Announces First Quarter Fiscal 2026 Financial Results

Cybeats Technologies Corp. reported Q1 fiscal 2026 results for the three months ended March 31, 2026. Revenue rose to $763,679 from $681,128 (+12%). Net loss widened to $2,430,993 from $1,185,102, with cash expenses down ~15% to $1,620,766. Cash fell to $1,072,900 from $2,751,202. The company also cited a Keysight OEM partnership and an automotive contract, and said it aims to reach ~$5M ARR by end of Q2 2026.

$KEYSLow

Keysight Tackles Semiconductor Talent Gap with Executable RF Design Whiteboard

Keysight Technologies said its RF Circuit Simulation Professional software now includes an “executable whiteboard” that captures an engineer’s RF design workflow—simulations, optimizations, decision trees, and parameters—into editable Python code. Keysight says the code can be saved, shared, and reused across Keysight ADS, Cadence Virtuoso, and Synopsys Custom Compiler. The company cited McKinsey’s estimate of an 88,000-engineer semiconductor gap by 2029.